{"rows":[{"id":5800,"title":"188. Mapping Psilocybin Therapy: A Systematic Review of Therapeutic Frameworks, Adaptations, and Standardization Across Contemporary Clinical Trials","authors":"Mary E. Kittur, L. Martínez, Brett D. M. Jones, Daniel M. Blumberger, Benoit H. Mulsant, Joshua D. Rosenblat, Ishrat Husain","journal":"Biological Psychiatry","publication_date":"2025-04-09","publication_year":2025,"doi":"10.1016/j.biopsych.2025.02.425","pubmed_id":null,"openalex_id":"https://openalex.org/W4409280622","source_url":"https://doi.org/10.1016/j.biopsych.2025.02.425","substance_tags":"psilocybin","topic_tags":"Pharmacology,Clinical Trial,Systematic Review,Review Article","study_type":"Systematic Review","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-09 08:25:21","last_checked":"2026-08-09 08:25:21","bibtex":null,"source_record_id":"DOI:10.1016/j.biopsych.2025.02.425","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2025.02.425","source_url":"https://doi.org/10.1016/j.biopsych.2025.02.425","doi":"10.1016/j.biopsych.2025.02.425","pmid":"","publication_date":"2025-04-09","importer_version":"2.1.3","text_redistributed":false}},{"id":5799,"title":"Precision Functional Mapping of Psilocybin’s Acute and Persistent Brain Effects","authors":"Subha Subramanian, Demetrius Perry, Travis Rick Renau, Ravi V. Chacko, Timothy O. Laumann, Karin Flavin, Christine Horan, Julia Schweiger, Nicholas V. Metcalf, Eric J. Lenze, Abraham Z. Snyder, Nico U.F. Dosenbach, Ginger E. Nicol, Joshua S. Siegel","journal":"Biological Psychiatry","publication_date":"2025-04-09","publication_year":2025,"doi":"10.1016/j.biopsych.2025.02.130","pubmed_id":null,"openalex_id":"https://openalex.org/W4409279932","source_url":"https://doi.org/10.1016/j.biopsych.2025.02.130","substance_tags":"psilocybin","topic_tags":"Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-09 08:25:21","last_checked":"2026-08-09 08:25:21","bibtex":null,"source_record_id":"DOI:10.1016/j.biopsych.2025.02.130","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2025.02.130","source_url":"https://doi.org/10.1016/j.biopsych.2025.02.130","doi":"10.1016/j.biopsych.2025.02.130","pmid":"","publication_date":"2025-04-09","importer_version":"2.1.3","text_redistributed":false}},{"id":5437,"title":"177. NMDA and 5-HT2A receptor dysfunction in working memory deficits in schizophrenia","authors":"Daniel Umbricht, F.X. Vollenweider, L. Schmid, R. Koller","journal":"Biological Psychiatry","publication_date":"2000-03-31","publication_year":2000,"doi":"10.1016/s0006-3223(00)00439-x","pubmed_id":null,"openalex_id":"https://openalex.org/W2104342516","source_url":"https://doi.org/10.1016/s0006-3223(00)00439-x","substance_tags":"psilocybin","topic_tags":"Pharmacology,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:07","last_checked":"2026-07-04 06:52:07","bibtex":null,"source_record_id":"DOI:10.1016/s0006-3223(00)00439-x","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/s0006-3223(00)00439-x","source_url":"https://doi.org/10.1016/s0006-3223(00)00439-x","doi":"10.1016/s0006-3223(00)00439-x","pmid":"","publication_date":"2000-03-31","importer_version":"2.1.3","text_redistributed":false}},{"id":5162,"title":"T263. Psilocybin Improves Cognitive Control and Downregulates Parietal Cortex in Treatment-Seeking Smokers","authors":"Michael C. McKenna, John R. Fedota, Albert Garcia-Romeu, Matthew R. Johnson, Roland R. Griffiths, Elliot A. Stein","journal":"Biological Psychiatry","publication_date":"2018-04-08","publication_year":2018,"doi":"10.1016/j.biopsych.2018.02.600","pubmed_id":null,"openalex_id":"https://openalex.org/W2797159874","source_url":"https://doi.org/10.1016/j.biopsych.2018.02.600","substance_tags":"psilocybin","topic_tags":"Addiction,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:02","last_checked":"2026-07-04 07:00:40","bibtex":null,"source_record_id":"DOI:10.1016/j.biopsych.2018.02.600","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2018.02.600","source_url":"https://doi.org/10.1016/j.biopsych.2018.02.600","doi":"10.1016/j.biopsych.2018.02.600","pmid":"","publication_date":"2018-04-08","importer_version":"2.1.3","text_redistributed":false}},{"id":5100,"title":"Altered Prediction-Error Processing May Underlie Psilocybin-Induced Changes in Self-Processing","authors":"Katrin H. Preller","journal":"Biological Psychiatry","publication_date":"2021-04-27","publication_year":2021,"doi":"10.1016/j.biopsych.2021.02.036","pubmed_id":null,"openalex_id":"https://openalex.org/W3159723459","source_url":"https://doi.org/10.1016/j.biopsych.2021.02.036","substance_tags":"psilocybin","topic_tags":"Depression,Eating Disorders,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:59","last_checked":"2026-08-09 08:25:46","bibtex":null,"source_record_id":"DOI:10.1016/j.biopsych.2021.02.036","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2021.02.036","source_url":"https://doi.org/10.1016/j.biopsych.2021.02.036","doi":"10.1016/j.biopsych.2021.02.036","pmid":"","publication_date":"2021-04-27","importer_version":"2.1.3","text_redistributed":false}},{"id":5099,"title":"Effects of Psilocybin on Suicidal Ideation in Patients With Life-Threatening Cancer","authors":"Julia Benville, Gabrielle Agin-Liebes, Daniel E. Roberts, Sharon L. Lo, Leila Ghazal, Silvia J. Franco-Corso, Stephen Ross","journal":"Biological Psychiatry","publication_date":"2021-04-27","publication_year":2021,"doi":"10.1016/j.biopsych.2021.02.591","pubmed_id":null,"openalex_id":"https://openalex.org/W3157975835","source_url":"https://doi.org/10.1016/j.biopsych.2021.02.591","substance_tags":"psilocybin","topic_tags":"End-of-Life Distress,Cancer Patients","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:59","last_checked":"2026-08-09 08:25:46","bibtex":null,"source_record_id":"DOI:10.1016/j.biopsych.2021.02.591","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2021.02.591","source_url":"https://doi.org/10.1016/j.biopsych.2021.02.591","doi":"10.1016/j.biopsych.2021.02.591","pmid":"","publication_date":"2021-04-27","importer_version":"2.1.3","text_redistributed":false}},{"id":4974,"title":"P388. Open Label Psilocybin Administration in Severely Treatment Resistant Depression","authors":"Scott Aaronson, Tammy Miller, Samuel Rudow, MacKenzie Forbes, Trisha Suppes","journal":"Biological Psychiatry","publication_date":"2022-04-27","publication_year":2022,"doi":"10.1016/j.biopsych.2022.02.624","pubmed_id":null,"openalex_id":"https://openalex.org/W4225010514","source_url":"https://doi.org/10.1016/j.biopsych.2022.02.624","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:57","last_checked":"2026-07-04 07:00:37","bibtex":null,"source_record_id":"DOI:10.1016/j.biopsych.2022.02.624","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2022.02.624","source_url":"https://doi.org/10.1016/j.biopsych.2022.02.624","doi":"10.1016/j.biopsych.2022.02.624","pmid":"","publication_date":"2022-04-27","importer_version":"2.1.3","text_redistributed":false}},{"id":4973,"title":"P450. Pilot Study Evaluation of Psilocybin Therapy for Anorexia Nervosa: Safety, Acceptability, and Preliminary Efficacy","authors":"Stéphanie Knatz Peck, Samatha Shao, Susan Murray, Walter H. Kaye","journal":"Biological Psychiatry","publication_date":"2022-04-27","publication_year":2022,"doi":"10.1016/j.biopsych.2022.02.686","pubmed_id":null,"openalex_id":"https://openalex.org/W4293242421","source_url":"https://doi.org/10.1016/j.biopsych.2022.02.686","substance_tags":"psilocybin","topic_tags":"Eating Disorders,Receptor Pharmacology,Safety","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:57","last_checked":"2026-07-04 07:00:37","bibtex":null,"source_record_id":"DOI:10.1016/j.biopsych.2022.02.686","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2022.02.686","source_url":"https://doi.org/10.1016/j.biopsych.2022.02.686","doi":"10.1016/j.biopsych.2022.02.686","pmid":"","publication_date":"2022-04-27","importer_version":"2.1.3","text_redistributed":false}},{"id":4826,"title":"Psychedelic Medicine: From Brain Science to Clinical Trials","authors":"David Nutt","journal":"Biological Psychiatry","publication_date":"2023-04-09","publication_year":2023,"doi":"10.1016/j.biopsych.2023.02.022","pubmed_id":null,"openalex_id":"https://openalex.org/W4363673488","source_url":"http://dx.doi.org/10.1016/j.biopsych.2023.02.022","substance_tags":"psilocybin","topic_tags":"Addiction,Brain Imaging,Receptor Pharmacology,Default Mode Network,Aging,Clinical Trial","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:46","last_checked":"2026-07-04 06:34:46","bibtex":null,"source_record_id":"DOI:10.1016/j.biopsych.2023.02.022","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2023.02.022","source_url":"http://dx.doi.org/10.1016/j.biopsych.2023.02.022","doi":"10.1016/j.biopsych.2023.02.022","pmid":"","publication_date":"2023-04-09","importer_version":"2.1.3","text_redistributed":false}},{"id":4825,"title":"509. Meta-Analysis of Functional Neuroimaging Studies of the Effects of Serotonergic Psychedelics on Neural Activity","authors":"Jonah H. Shepherd, Caitlin Baten, Amanda M. Klassen, Gladys Zamora, Sarah Saravia, Elizabeth Pritchard, Zulaikha Ali, Saneh K. Kahlon, Kyla Whitelock, Fabiola A. Reyes, Dawson H. Hedges, J. Paul Hamilton, Matthew D. Sacchet, Chris H. Miller","journal":"Biological Psychiatry","publication_date":"2023-04-09","publication_year":2023,"doi":"10.1016/j.biopsych.2023.02.749","pubmed_id":null,"openalex_id":"https://openalex.org/W4363648473","source_url":"http://dx.doi.org/10.1016/j.biopsych.2023.02.749","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Receptor Pharmacology,Aging,Meta-Analysis","study_type":"Meta-Analysis","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:46","last_checked":"2026-07-04 06:34:46","bibtex":null,"source_record_id":"DOI:10.1016/j.biopsych.2023.02.749","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2023.02.749","source_url":"http://dx.doi.org/10.1016/j.biopsych.2023.02.749","doi":"10.1016/j.biopsych.2023.02.749","pmid":"","publication_date":"2023-04-09","importer_version":"2.1.3","text_redistributed":false}},{"id":4824,"title":"118. Does Psilocybin Change Synaptic Vesicular Density in the Brains of Patients With Mild Cognitive Impairment?","authors":"Aron Amaev, Jianmeng Song, Yasaman Kambari, Fumihiko Ueno, Edgardo Torres-Carmona, Ali Abdolizadeh, Teruki Koizumi, Vincenzo De Luca, Bruce G. Pollock, Alastair J. Flint, Muhammad Ishrat Husain, Ariel Graff-Guerrero, Philip Gerretsen","journal":"Biological Psychiatry","publication_date":"2023-04-10","publication_year":2023,"doi":"10.1016/j.biopsych.2023.02.358","pubmed_id":null,"openalex_id":"https://openalex.org/W4362734001","source_url":"https://doi.org/10.1016/j.biopsych.2023.02.358","substance_tags":"psilocybin","topic_tags":"Neuroplasticity,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:46","last_checked":"2026-08-09 08:25:36","bibtex":null,"source_record_id":"DOI:10.1016/j.biopsych.2023.02.358","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2023.02.358","source_url":"https://doi.org/10.1016/j.biopsych.2023.02.358","doi":"10.1016/j.biopsych.2023.02.358","pmid":"","publication_date":"2023-04-10","importer_version":"2.1.3","text_redistributed":false}},{"id":4823,"title":"347. Changes in Resting State Functional Connectivity After Psilocybin for Body Dysmorphic Disorder","authors":"Xi Zhu, David J. Hellerstein, Jamie D. Feusner, Michael G. Wheaton, Gloria Gómez, Franklin R. Schneier","journal":"Biological Psychiatry","publication_date":"2023-04-10","publication_year":2023,"doi":"10.1016/j.biopsych.2023.02.587","pubmed_id":null,"openalex_id":"https://openalex.org/W4362733849","source_url":"https://doi.org/10.1016/j.biopsych.2023.02.587","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:46","last_checked":"2026-08-09 08:25:36","bibtex":null,"source_record_id":"DOI:10.1016/j.biopsych.2023.02.587","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2023.02.587","source_url":"https://doi.org/10.1016/j.biopsych.2023.02.587","doi":"10.1016/j.biopsych.2023.02.587","pmid":"","publication_date":"2023-04-10","importer_version":"2.1.3","text_redistributed":false}},{"id":4822,"title":"96. An Open Label Study of Synthetic Psilocybin in Bipolar Type II Depression","authors":"Scott Aaronson, Tammy Miller, Samuel Rudow, MacKenzie Forbes, Audrey Shoultz, Trisha Suppes","journal":"Biological Psychiatry","publication_date":"2023-04-10","publication_year":2023,"doi":"10.1016/j.biopsych.2023.02.336","pubmed_id":null,"openalex_id":"https://openalex.org/W4363675215","source_url":"https://doi.org/10.1016/j.biopsych.2023.02.336","substance_tags":"psilocybin","topic_tags":"Depression","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:46","last_checked":"2026-08-09 08:25:36","bibtex":null,"source_record_id":"DOI:10.1016/j.biopsych.2023.02.336","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2023.02.336","source_url":"https://doi.org/10.1016/j.biopsych.2023.02.336","doi":"10.1016/j.biopsych.2023.02.336","pmid":"","publication_date":"2023-04-10","importer_version":"2.1.3","text_redistributed":false}},{"id":4635,"title":"1. Psilocybin and 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) at Encoding Distort Episodic Familiarity and Positively Bias Emotional Metamemory","authors":"Manoj K. Doss, Pablo Mallaroni, Natasha L. Mason, Jan Ramaekers","journal":"Biological Psychiatry","publication_date":"2024-04-29","publication_year":2024,"doi":"10.1016/j.biopsych.2024.02.179","pubmed_id":null,"openalex_id":"https://openalex.org/W4396235155","source_url":"https://doi.org/10.1016/j.biopsych.2024.02.179","substance_tags":"psilocybin","topic_tags":"Emotional Processing","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-08-09 08:25:29","bibtex":null,"source_record_id":"DOI:10.1016/j.biopsych.2024.02.179","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2024.02.179","source_url":"https://doi.org/10.1016/j.biopsych.2024.02.179","doi":"10.1016/j.biopsych.2024.02.179","pmid":"","publication_date":"2024-04-29","importer_version":"2.1.3","text_redistributed":false}},{"id":4403,"title":"458. Microdoses of Psilocybin Combined With Eugenol are Absorbed and Induce Unique Cerebellar Gene Expression","authors":"Chuck T. Chen, Aidan D Tyrrell, Darryl Hudson, Ralph Landau, Adam H. Metherel, Richard P. Bazinet","journal":"Biological Psychiatry","publication_date":"2025-04-09","publication_year":2025,"doi":"10.1016/j.biopsych.2025.02.696","pubmed_id":null,"openalex_id":"https://openalex.org/W4409294360","source_url":"https://doi.org/10.1016/j.biopsych.2025.02.696","substance_tags":"psilocybin","topic_tags":"Pharmacology,Microdosing","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:40","last_checked":"2026-08-09 08:25:21","bibtex":null,"source_record_id":"DOI:10.1016/j.biopsych.2025.02.696","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2025.02.696","source_url":"https://doi.org/10.1016/j.biopsych.2025.02.696","doi":"10.1016/j.biopsych.2025.02.696","pmid":"","publication_date":"2025-04-09","importer_version":"2.1.3","text_redistributed":false}},{"id":4402,"title":"630. Synthetic Psilocybin (COMP360) for Chronic Active Suicidal Ideation: An Open-Label Study","authors":"Scott Aaronson, Tammy Miller, Audrey Shoultz, Bryce Lund, Jeffrey LaPratt, Margo Lauterbach, Kim Swartz, Andrew van der Vaart","journal":"Biological Psychiatry","publication_date":"2025-04-09","publication_year":2025,"doi":"10.1016/j.biopsych.2025.02.869","pubmed_id":null,"openalex_id":"https://openalex.org/W4409281909","source_url":"https://doi.org/10.1016/j.biopsych.2025.02.869","substance_tags":"psilocybin","topic_tags":"Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:40","last_checked":"2026-08-09 08:25:21","bibtex":null,"source_record_id":"DOI:10.1016/j.biopsych.2025.02.869","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2025.02.869","source_url":"https://doi.org/10.1016/j.biopsych.2025.02.869","doi":"10.1016/j.biopsych.2025.02.869","pmid":"","publication_date":"2025-04-09","importer_version":"2.1.3","text_redistributed":false}},{"id":4401,"title":"194. Improving Workplace and Psychosocial Function in Treatment-Resistant Depression: Exploratory Outcomes From an Open-Label Feasibility Trial of Psilocybin-Assisted Psychotherapy","authors":"Orly Lipsitz, Joshua D. Rosenblat","journal":"Biological Psychiatry","publication_date":"2025-04-09","publication_year":2025,"doi":"10.1016/j.biopsych.2025.02.431","pubmed_id":null,"openalex_id":"https://openalex.org/W4409281338","source_url":"https://doi.org/10.1016/j.biopsych.2025.02.431","substance_tags":"psilocybin","topic_tags":"Depression,Randomized Controlled Trial,Treatment-Resistant Depression","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:40","last_checked":"2026-08-09 08:25:21","bibtex":null,"source_record_id":"DOI:10.1016/j.biopsych.2025.02.431","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2025.02.431","source_url":"https://doi.org/10.1016/j.biopsych.2025.02.431","doi":"10.1016/j.biopsych.2025.02.431","pmid":"","publication_date":"2025-04-09","importer_version":"2.1.3","text_redistributed":false}},{"id":4400,"title":"187. Changes in Symptoms of Anhedonia With Psilocybin-Assisted Psychotherapy: A Secondary Analysis of a Randomized Clinical Trial for Treatment-Resistant Depression","authors":"Erica Kaczmarek, Nelson B. Rodrigues, Noah Chisamore, Zoe Doyle, Roger S. McIntyre, Rodrigo B. Mansur, Joshua D. Rosenblat","journal":"Biological Psychiatry","publication_date":"2025-04-09","publication_year":2025,"doi":"10.1016/j.biopsych.2025.02.424","pubmed_id":null,"openalex_id":"https://openalex.org/W4409281325","source_url":"https://doi.org/10.1016/j.biopsych.2025.02.424","substance_tags":"psilocybin","topic_tags":"Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:40","last_checked":"2026-08-09 08:25:21","bibtex":null,"source_record_id":"DOI:10.1016/j.biopsych.2025.02.424","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2025.02.424","source_url":"https://doi.org/10.1016/j.biopsych.2025.02.424","doi":"10.1016/j.biopsych.2025.02.424","pmid":"","publication_date":"2025-04-09","importer_version":"2.1.3","text_redistributed":false}},{"id":4399,"title":"186. Assessing Cognitive Outcomes in Treatment-Resistant Depression Following Psilocybin-Assisted Psychotherapy","authors":"Danica E. Johnson, Erica Kaczmarek, Noah Chisamore, Orly Lipitz, Zoe Doyle, Rodrigo B. Mansur, Roger S. McIntyre, Joshua D. Rosenblat","journal":"Biological Psychiatry","publication_date":"2025-04-09","publication_year":2025,"doi":"10.1016/j.biopsych.2025.02.423","pubmed_id":null,"openalex_id":"https://openalex.org/W4409281322","source_url":"https://doi.org/10.1016/j.biopsych.2025.02.423","substance_tags":"psilocybin","topic_tags":"Depression,Treatment-Resistant Depression","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:40","last_checked":"2026-08-09 08:25:21","bibtex":null,"source_record_id":"DOI:10.1016/j.biopsych.2025.02.423","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2025.02.423","source_url":"https://doi.org/10.1016/j.biopsych.2025.02.423","doi":"10.1016/j.biopsych.2025.02.423","pmid":"","publication_date":"2025-04-09","importer_version":"2.1.3","text_redistributed":false}},{"id":4398,"title":"58. Acute Behavioral Effects of Psilocybin and Its Pharmacokinetics in Nonhuman Primates","authors":"Ashton Barber, Sydney Gifford, Patrick H. Roseboom, Jonathan A. Oler, Nate Jones, Molly C. Pellitteri-Hahn, Cameron O. Scarlett, Cody J. Wenthur, Paul R. Hutson, Ned H. Kalin","journal":"Biological Psychiatry","publication_date":"2025-04-09","publication_year":2025,"doi":"10.1016/j.biopsych.2025.02.295","pubmed_id":null,"openalex_id":"https://openalex.org/W4409280771","source_url":"https://doi.org/10.1016/j.biopsych.2025.02.295","substance_tags":"psilocybin","topic_tags":"Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:40","last_checked":"2026-08-09 08:25:21","bibtex":null,"source_record_id":"DOI:10.1016/j.biopsych.2025.02.295","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2025.02.295","source_url":"https://doi.org/10.1016/j.biopsych.2025.02.295","doi":"10.1016/j.biopsych.2025.02.295","pmid":"","publication_date":"2025-04-09","importer_version":"2.1.3","text_redistributed":false}}],"total":32,"page":1,"per_page":20,"pages":2,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Biological Psychiatry","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}